A61K 9/282
Organic compounds
Official title: {Organic compounds, e.g. fats}
A61K9/282 (Organic compounds) appears on 525 US grants and 944 published applications in this corpus.
Search patents in A61K- Granted patents
- 525
- Published applications
- 944
- Assignees
- 408
- Inventors
- 1,612
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 9 | 0 |
| 2001 | 10 | 3 |
| 2002 | 8 | 14 |
| 2003 | 12 | 30 |
| 2004 | 10 | 38 |
| 2005 | 12 | 44 |
| 2006 | 9 | 25 |
| 2007 | 13 | 42 |
| 2008 | 7 | 17 |
| 2009 | 5 | 28 |
| 2010 | 11 | 28 |
| 2011 | 22 | 39 |
| 2012 | 16 | 46 |
| 2013 | 21 | 36 |
| 2014 | 29 | 46 |
| 2015 | 26 | 46 |
| 2016 | 23 | 49 |
| 2017 | 36 | 63 |
| 2018 | 27 | 39 |
| 2019 | 22 | 48 |
| 2020 | 30 | 36 |
| 2021 | 20 | 49 |
| 2022 | 24 | 43 |
| 2023 | 18 | 38 |
| 2024 | 14 | 36 |
| 2025 | 17 | 30 |
| 2026 | 15 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- High opacity coatings and substrates coated therewith15 Sep 2026US 12,734,133 B2BPSI Holdings, Inc.
- Polyglycerol fatty acid ester-containing composition11 Aug 2026US 12,703,142 B2Ioi Oleo GmbH
- Pharmaceutical composition14 Jul 2026US 12,678,426 B2Kowa Company, Ltd.
- DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation14 Jul 2026US 12,678,442 B2Boehringer Ingelheim International GmbH
- Substituted tetrazoles as ACSS2 inhibitors7 Jul 2026US 12,673,046 B2Merck Patent GmbH
- Natural aqueous film-forming composition based on a pair of starches1 Oct 2026US 2026/0294815 A1Swiss Applied Coating Research GmbH
- Methods of treating erythropoietic protoporphyria or x-linked protoporphyria with bitopertin1 Oct 2026US 2026/0294899 A1Disc Medicine, Inc.
- Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide1 Oct 2026US 2026/0294904 A1Hoffmann-La Roche Inc.
- Dietary supplement for pain and stress1 Oct 2026US 2026/0294994 A1
- Delayed timed release pharmaceutical composition, preparation method therefor, and use thereof10 Sep 2026US 2026/0263349 A1Shanghai Wd Pharmaceutical Co., Ltd
Most cited
By later US patents
- Pharmaceutical delivery system309US 4,687,660 ABurroughs Wellcome Co. · 1987
- Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations234US 6,046,177 ACydex, Inc. · 2000
- Membrane-coated sustained-release tablets and method151US 4,557,925 AAB Ferrosan · 1985
- Controlled release hydrocodone formulations145US 7,943,174 B2Purdue Pharma L. P. · 2011
- Method for providing enteric coating on solid dosage forms and aqueous compositions therefor118US 4,385,078 AShin-Etsu Chemical Co., Ltd. · 1983